diffregen.com
Contact us
About company
Diffregen is a startup focused on development of new leukemia drug candidates. Their active ingredients are based on Angiocidin, a protein which has been shown to activate monocytes and drive terminal differentiation of leukemia cells.
Unknown
Unknown
Not verified company
